PANIXINE DISPERDOSE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Panixine Disperdose, and when can generic versions of Panixine Disperdose launch?
Panixine Disperdose is a drug marketed by Ranbaxy Labs Ltd and is included in one NDA.
The generic ingredient in PANIXINE DISPERDOSE is cephalexin. There are twenty-nine drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the cephalexin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Panixine Disperdose
A generic version of PANIXINE DISPERDOSE was approved as cephalexin by TEVA on February 13th, 1987.
Summary for PANIXINE DISPERDOSE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Clinical Trials: | 1 |
Patent Applications: | 4,161 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PANIXINE DISPERDOSE at DailyMed |
Recent Clinical Trials for PANIXINE DISPERDOSE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Merck Sharp & Dohme Corp. | Phase 1 |
US Patents and Regulatory Information for PANIXINE DISPERDOSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ranbaxy Labs Ltd | PANIXINE DISPERDOSE | cephalexin | TABLET, FOR SUSPENSION;ORAL | 065100-002 | Sep 11, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ranbaxy Labs Ltd | PANIXINE DISPERDOSE | cephalexin | TABLET, FOR SUSPENSION;ORAL | 065100-001 | Sep 11, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |